跳至主要内容
临床试验/ACTRN12622001483741
ACTRN12622001483741尚未招募4 期

ebulised fentanyl for labour pain – a pharmacokinetic and feasibility study in low risk pregnant patients

The Royal Brisbane and Women's Hospital0 个研究点目标入组 15 人开始时间: 2022年11月28日最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
15

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 50 Years(—)
性别
Female

入选标准

  • Age greater than or equal to 18 years and less than or equal to 50 years, gestation greater than or equal to 37 weeks, early pregnancy body mass index greater than or equal to 16 and less than or equal to 40 kg/m2, planning a vaginal delivery or a vaginal birth after caesarean section, able to understand information and consent form in English and provide informed consent.
  • Midwives who are providing clinical care for participants will be offered the opportunity to voluntarily and in a de-identified fashion to provide feedback on the use of nebulised fentanyl.

排除标准

  • Multiple pregnancy, fetus with congenital anomaly, pre-eclampsia, cardiovascular or respiratory disease with New York Heart Association (NYHA) score >2, epilepsy on medication, diabetes on medication, elevated serum creatinine (>70 µmol/L), known opioid misuse, allergy to fentanyl, fentanyl administered by any route in the 24 hours prior to active labour.

研究者

发起方
The Royal Brisbane and Women's Hospital

相似试验